KENDALL CAPITAL MANAGEMENT – Jazz Pharmaceuticals plc Transaction History
KENDALL CAPITAL MANAGEMENT portfolio value:
$431,000
portfolio value
KENDALL CAPITAL MANAGEMENT quarter portfolio value change:
-14.56%
quarter
Jazz Pharmaceuticals plc 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -7.45% | -260 shares | -113K | $133.29 | 3.23K |
Q2 2022 | share | Decrease | -36.55% | -2.01K shares | -312K | $156.01 | 3.49K |
Q1 2022 | share | Decrease | -26.62% | -1.99K shares | -99K | $155.67 | 5.5K |
Q4 2021 | share | Decrease | -12.95% | -1.11K shares | -166K | $128.26 | 7.49K |
Q3 2021 | share | Increase | +5.00% | 410 shares | -336K | $130.21 | 8.61K |
Q2 2021 | share | Increase | +5.60% | 435 shares | 181K | $177.64 | 8.2K |
Q1 2021 | share | Increase | +6.74% | 490 shares | 75K | $164.37 | 7.76K |
Q4 2020 | share | Increase | +1.75% | 125 shares | 181K | $165.05 | 7.27K |
Q3 2020 | share | Increase | +8.25% | 545 shares | 291K | $142.59 | 7.15K |
Q2 2020 | share | Increase | +19.76% | 1.09K shares | 179K | $110.34 | 6.60K |
Q1 2020 | share | Decrease | -1.87% | -105 shares | -289K | $99.74 | 5.51K |
Q4 2019 | share | Increase | +15.16% | 740 shares | 214K | $149.28 | 5.62K |
Q3 2019 | share | Increase | +143.39% | 2.87K shares | 339K | $128.14 | 4.88K |
Q2 2019 | share | Increase | 0.00% | 2.00K shares | 286K | $142.56 | 2.00K |